Elite in Calciphylaxis

Mario G. Cozzolino

ASST Santi Paolo E Carlo
Milan, IT 
Elite in Calciphylaxis
ASST Santi Paolo E Carlo
Milan, IT 
OverviewLocationsClinical Research

Overview

Mario Cozzolino practices in Milan, Italy. Mr. Cozzolino is rated as an Elite expert by MediFind in the treatment of Calciphylaxis. His top areas of expertise are Calcinosis, Hyperparathyroidism, Malnutrition, Kidney Transplant, and Parathyroidectomy.

His clinical research consists of co-authoring 342 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 10 articles in the study of Calciphylaxis.

Gender
Male

Locations

ASST Santi Paolo e Carlo
Milan, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase 3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Autosomal Dominant Polycystic Kidney Disease
A Phase 3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Autosomal Dominant Polycystic Kidney Disease
Enrollment Status: Terminated
Publish Date: June 03, 2025
Intervention Type: Drug
Study Drug: Bardoxolone
Study Phase: Phase 3
A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Darbepoetin Alfa
A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Darbepoetin Alfa
Enrollment Status: Completed
Publish Date: April 02, 2024
Intervention Type: Drug
Study Drugs: Daprodustat, Darbepoetin Alpha
Study Phase: Phase 3
A Phase IV, Open-Label, Multi-Centre Trial Evaluating the Conversion From Standard Phosphate Binder Therapy to Fosrenol® in Chronic Kidney Disease Stage 5 Patients on Haemodialysis
A Phase IV, Open-Label, Multi-Centre Trial Evaluating the Conversion From Standard Phosphate Binder Therapy to Fosrenol® in Chronic Kidney Disease Stage 5 Patients on Haemodialysis
Enrollment Status: Terminated
Publish Date: May 25, 2021
Intervention Type: Drug
Study Phase: Phase 4
Vitamin K1 to Slow Progression of Vascular Calcification in Hemodialysis Patients
Vitamin K1 to Slow Progression of Vascular Calcification in Hemodialysis Patients
Enrollment Status: Terminated
Publish Date: October 08, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 3 Less Clinical Trials

342 Total Publications

RAASi, MRA and FGF-23 in CKD progression: the usual suspects?
RAASi, MRA and FGF-23 in CKD progression: the usual suspects?
Journal: Minerva urology and nephrology
Published: September 05, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Cozzolino's expertise for a condition
ConditionClose
View All 30 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile